Evidence map›Paper›PMID 36552054›Full record

ArticleBrain sciences2022

Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria.

Joseph R Phillips, Elie Matar, Kaylena A Ehgoetz Martens, Ahmed A Moustafa, Glenda M Halliday, Simon J G Lewis

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Joseph R PhillipsFaculty of Medicine and Health, Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW 2050, Australia.ORCID 0000-0001-8239-7512
Elie MatarFaculty of Medicine and Health, Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW 2050, Australia.ORCID 0000-0002-4994-0488
Kaylena A Ehgoetz MartensFaculty of Medicine and Health, Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW 2050, Australia.
Ahmed A MoustafaDepartment of Human Anatomy and Physiology, The Faculty of Health Sciences, University of Johannesburg, Johannesburg 2092, South Africa.
Glenda M HallidayFaculty of Medicine and Health, Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW 2050, Australia.ORCID 0000-0003-0422-8398
Simon J G LewisFaculty of Medicine and Health, Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW 2050, Australia.
The University of Sydney · AUBond University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dementia with Lewy bodies (DLB) is an insidious neurodegenerative disease characterised by a precipitous decline in cognition, sleep disturbances, motor impairment and psychiatric features. Recently, criteria for prodromal DLB (pDLB) including clinical features and biomarkers have been put forward to aid the classification and research of this ambiguous cohort of patients. Researchers can use these criteria to classify patients with mild cognitive impairment (MCI) with Lewy bodies (MCI-LB) as either possible (either one core clinical feature or one biomarker are present) or probable pDLB (at least two core clinical features, or one core clinical feature and at least one biomarker present). However, as isolated REM sleep behaviour disorder (iRBD) confirmed with polysomnography (PSG) can be included as both a clinical and a biomarker feature, potentially reducing the specificity of these diagnostic criteria. To address this issue, the current study classified a cohort of 47 PSG-confirmed iRBD patients as probable prodromal DLB only in the presence of an additional core feature or if there was an additional non-PSG biomarker. Thirteen iRBD patients demonstrated MCI (iRBD-MCI). In the iRBD-MCI group, one presented with parkinsonism and was thus classified as probable pDLB, whilst the remaining 12 were classified as only possible pDLB. All patients performed three tasks designed to measure attentional deficits, visual hallucinations and visuospatial impairment. Patients also attended clinical follow-ups to monitor for transition to DLB or another synucleinopathy. Findings indicated that the only patient categorised by virtue of having two core clinical features as probable pDLB transitioned over 28 months to a diagnosis of DLB. The performance of this probable pDLB patient was also ranked second-highest for their hallucinatory behaviours and had comparatively lower visuospatial accuracy. These findings highlight the need for more stringent diagnostic research criteria for pDLB, given that only one of the 13 patients who would have satisfied the current guidelines for probable pDLB transitioned to DLB after two years and was indeed the patient with two orthogonal core clinical features.

Indexed as

attentiondementia with Lewy bodies (DLB)diagnostic criteriaisolated REM sleep behaviour disorder (iRBD)prodromalvisual hallucinationsvisuospatial

Identifiers

PMID36552054
PMCPMC9775171
OpenAlexW4309681117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.